A 70-year-old man with COPD (FEV1 45% of predicted) reports increased dyspnoea and sputum production. He is on a LABA. According to NICE guidelines, w...

Question

A 70-year-old man with COPD (FEV1 45% of predicted) reports increased dyspnoea and sputum production. He is on a LABA. According to NICE guidelines, what is the next best inhaled therapy to add?

Accepted Answer

Long-acting muscarinic antagonist (LAMA)

Answer

High-dose inhaled corticosteroid

Answer

Short-acting antimuscarinic agent (ipratropium)

Answer

Roflumilast

Answer

Oral theophylline

ukmla MCQ (SBA): COPD

A 70-year-old man with COPD (FEV1 45% of predicted) reports increased dyspnoea and sputum production. He is on a LABA. According to NICE guidelines, what is the next best inhaled therapy to add?